chr11-108332765-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.7792C>T(p.Arg2598*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,612,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R2598R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4 | c.7792C>T | p.Arg2598* | stop_gained | Exon 53 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151942Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249878 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460114Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726400 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151942Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74190 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
This variant changes 1 nucleotide in exon 53 of the ATM gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been identified in 3/249878 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
The p.R2598* pathogenic mutation (also known as c.7792C>T), located in coding exon 52 of the ATM gene, results from a C to T substitution at nucleotide position 7792. This changes the amino acid from an arginine to a stop codon within coding exon 52. This mutation has been reported in multiple individuals with ataxia-telangiectasia in the literature, including a Brazilian patient who was compound heterozygous for this mutation and a second pathogenic ATM mutation (Wright J et al. Am. J. Hum. Genet. 1996 Oct;59:839-46; Chessa L et al. Prenat. Diagn. 1999 Jun;19:542-5; Mitui M et al. Hum. Mutat. 2003 Jul;22:43-50; Coutinho G et al. Am. J. Med. Genet. A. 2004 Apr;126A:33-40; Lin L et al. Stem Cell Reports. 2015 Dec;5:1097-1108). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Familial cancer of breast Pathogenic:2
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Ataxia-telangiectasia syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg2598*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 8808599, 10864201, 12815592, 26677768). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 265383). Studies have shown that this premature translational stop signal is associated with inconclusive levels of altered splicing (internal data). For these reasons, this variant has been classified as Pathogenic. -
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast Pathogenic:1
- -
ATM-related disorder Pathogenic:1
This nonsense variant found in exon 53 of 63 is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been reported as compound heterozygous change in patients with ataxia-telangiectasia (PMID: 8808599, 12815592, 10864201, 26677768). It has also been reported as a heterozygous change in an individual with pancreatic cancer (PMID: 32255556). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.001% (3/249878) and thus is presumed to be rare. Based on the available evidence, the c.7792C>T (p.Arg2598Ter) variant is classified as Pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Observed in at least three ataxia-telangiectasia patients, two of whom were identified to carry a second ATM truncating variant (Wright et al., 1996; Mitui et al., 2003; Lin et al., 2015); This variant is associated with the following publications: (PMID: 12815592, 25525159, 26677768, 8808599, 26053404, 32255556, 31948886, 32853339, 15039971, 25614872, 29922827, 10416970, 23807571, 35014770, 34954471, 35365198, 10864201, Zhang2017[preprint], Sultanbeav2021[poster]) -
Gastric cancer Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at